Kathleen N. Moore

Kathleen N. Moore, MD, MS, FASCO

Virginia Kerley Cade Chair in Developmental Therapeutics
Deputy Director, Stephenson Cancer Center at OU Health
Oklahoma City, Oklahoma

Explore Activities by Kathleen N. Moore

Title
Format
Credit Type
Credits
United in Care: Advancing Effective Gynecologic Cancer Treatment Strategies Through Enhanced Patient and Care Team Education & Coordination

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
United in Care: Advancing Gynecologic Cancer Treatment Strategies Through Enhanced Patient and Care Team Education & Coordination

Content Format:

Slideset

Credit Type:

--

Credits:

--
Immunotherapy Advances in Gynecologic Cancers: Insights From ASCO 2024

Content Format:

Clinical Thought

Credit Type:

AMA

Credits:

0.25
Emerging HER2-Targeted Antibody–Drug Conjugates in Gynecologic Cancers

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.75
Think Tank on Emerging HER2-Targeted ADCs in Genitourinary, Gastrointestinal, and Gynecologic Malignancies

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Expert Analyses of Key Clinical Developments and Updates Across Gynecologic Malignancies: Independent 2023 Conference/Congress Coverage

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.50
Expert Commentary and Insight on Key Data From the 2023 ASCO Annual Meeting Informing Treatment for Endometrial, Cervical, and Ovarian Cancers

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Expert Insight on Key Updates and New Clinical Trial Data From the 2023 ASCO Annual Meeting, Informing Treatment for Cervical, Ovarian, and Endometrial Cancers

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Slides: Expert Insight Key Data From ASCO 2023 Informing Treatment for Endometrial, Cervical, and Ovarian Cancers

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Expert Strategies for Managing Adverse Events With Combination Immune Checkpoint Inhibitor/Targeted Therapy

Content Format:

Text Module

Credit Type:

ACPE | AMA

Credits:

1.00
Managing Adverse Events With Combination Immune Checkpoint Inhibitor/Targeted Therapy

Content Format:

Slideset

Credit Type:

--

Credits:

--
Slides: CCO 2023 Global Conference Coverage: Gynecologic Cancers Updates

Content Format:

Slideset

Credit Type:

--

Credits:

--
Why I Have Renewed Hope for Better Treatment of Platinum-Resistant Ovarian Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Interactive Decision Support Tool: Treatment Selection for Patients With Advanced Ovarian Cancer

Content Format:

Tool

Credit Type:

--

Credits:

--
Cancer Conversations™ PARP Inhibitors in Ovarian Cancer

Content Format:

Case Challenge

Credit Type:

AMA

Credits:

0.75
ExpressPointsCancer Conversations™: PARP Inhibitors in Ovarian Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Cancer Conversations™: PARP Inhibitors in Ovarian Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Treatment Options From 5 Experts for Advanced Ovarian Cancer: An Online Tool for Patients

Content Format:

Tool

Credit Type:

--

Credits:

--
My Thoughts on the Clinical Implications of the Expanded Indication for Niraparib

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--